(Q36984865)

17 August 2017

1 reference

title

CD4+CD25+FoxP3+ regulatory T cells in autoimmune diseases (English)

1 reference

17 August 2017

Xavier Valencia

1

1 reference

17 August 2017

Peter E Lipsky

series ordinal

2

1 reference

17 August 2017

publication date

1 November 2007

1 reference

Nature Clinical Practice Rheumatology

17 August 2017

published in

1 reference

17 August 2017

volume

3

1 reference

17 August 2017

issue

11

1 reference

17 August 2017

page(s)

619-626

1 reference

A role for TGF-beta in the generation and expansion of CD4+CD25+ regulatory T cells from human peripheral blood

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0624

Cutting Edge: IL-2 is essential for TGF-beta-mediated induction of Foxp3+ T regulatory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0624

Deficient CD4+CD25high T regulatory cell function in patients with active systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0624

Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0624

7 January 2021

CD4+ CD25+ suppressor T cells: more questions than answers

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0624

7 January 2021

CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0624

7 January 2021

CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0624

7 January 2021

Regulatory T cells mediate maternal tolerance to the fetus

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0624

7 January 2021

Mast cells are essential intermediaries in regulatory T-cell tolerance

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0624

7 January 2021

Certified professionals: CD4(+)CD25(+) suppressor T cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0624

7 January 2021

Control of regulatory T cell development by the transcription factor Foxp3

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0624

7 January 2021

Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0624

7 January 2021

Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0624

7 January 2021

Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0624

7 January 2021

Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25– T cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0624

7 January 2021

TNF downmodulates the function of human CD4+CD25hi T-regulatory cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0624

7 January 2021

Suppressor T cells in human diseases

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0624

7 January 2021

CD4+CD25high regulatory cells in human peripheral blood

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0624

7 January 2021

CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0624

7 January 2021

Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0624

7 January 2021

Interleukin-7 is a survival factor for CD4+ CD25+ T-cells and is expressed by diabetes-suppressive dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0624

7 January 2021

Isolation and functional characterization of regulatory CD25brightCD4+ T cells from the target organ of patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0624

7 January 2021

Epitope-specific immunotherapy induces immune deviation of proinflammatory T cells in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0624

7 January 2021

Role of cytokines in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0624

7 January 2021

T cell self-reactivity forms a cytokine milieu for spontaneous development of IL-17+ Th cells that cause autoimmune arthritis.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0624

7 January 2021

Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0624

7 January 2021

Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0624

7 January 2021

Anti-TNF-alpha therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-beta

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0624

7 January 2021

IL-17 family cytokines and the expanding diversity of effector T cell lineages

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0624

7 January 2021

TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0624

7 January 2021

Systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0624

7 January 2021

Systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0624

7 January 2021

Cutting edge: direct suppression of B cells by CD4+ CD25+ regulatory T cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0624

7 January 2021

Regulatory T cells can migrate to follicles upon T cell activation and suppress GC-Th cells and GC-Th cell-driven B cell responses

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0624

7 January 2021

Quantification of regulatory T cells in patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0624

7 January 2021

Decreased CD4+CD25+ T cells in peripheral blood of patients with systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0624

7 January 2021

Inverse correlation between CD4+ regulatory T-cell population and autoantibody levels in paediatric patients with systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0624

7 January 2021

Global Natural Regulatory T Cell Depletion in Active Systemic Lupus Erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0624

7 January 2021

A function for interleukin 2 in Foxp3-expressing regulatory T cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0624

7 January 2021

T cell abnormalities in human and mouse lupus: intrinsic and extrinsic

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0624

7 January 2021

Tumour necrosis factor and other proinflammatory cytokines in systemic lupus erythematosus: a rationale for therapeutic intervention

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0624

7 January 2021

Type I interferon in systemic lupus erythematosus and other autoimmune diseases

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0624

7 January 2021

Low number of regulatory T cells in skin lesions of patients with cutaneous lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0624

7 January 2021

CD4 CD25high regulatory T cells are not impaired in patients with primary Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0624

7 January 2021

Functional defect of circulating regulatory CD4+ T cells in patients with Wegener's granulomatosis in remission

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0624

7 January 2021

The immune paradox of sarcoidosis and regulatory T cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0624

7 January 2021

Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0624

7 January 2021

Reduced suppressive effect of CD4+CD25high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0624

7 January 2021

Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0624

7 January 2021

Functional defect of regulatory CD4(+)CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0624

7 January 2021

Circulating and thymic CD4 CD25 T regulatory cells in myasthenia gravis: effect of immunosuppressive treatment

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0624

7 January 2021

The Wiskott-Aldrich syndrome protein is required for the function of CD4(+)CD25(+)Foxp3(+) regulatory T cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0624

7 January 2021

How defects in central tolerance impinge on a deficiency in regulatory T cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0624

7 January 2021

Identifiers

DOI

10.1038/NCPRHEUM0624

1 reference

17 August 2017

1 reference